Smith & Nephew (SNN) Income from Non-Controlling Interests (2009 - 2021)

Smith & Nephew (SNN) posted quarterly Income from Non-Controlling Interests of $20.0 million for Q4 2021, up 126.32% year-on-year from $8.8 million in Q4 2020, and up 126.32% on a QoQ basis from -$76.0 million in Q4 2020.

Smith & Nephew (SNN) Income from Non-Controlling Interests (2009 - 2021) Analysis & Trends

Smith & Nephew (SNN) has reported Income from Non-Controlling Interests for 6 consecutive years, with $20.0 million the latest figure, recorded in Q4 2021.

  • Quarterly Income from Non-Controlling Interests rose 126.32% year-over-year to $20.0 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was -$154.0 million (down 50.98% YoY) and the FY2022 annual result came in at -$90.0 million, down 325.0% from the prior year.
  • Income from Non-Controlling Interests advanced to $20.0 million in Q4 2021 per SNN's latest filing, from -$76.0 million in the prior quarter.
  • Over the last five years, Income from Non-Controlling Interests for SNN reached as high as $20.0 million in Q4 2021 and fell as low as -$102.0 million in Q4 2018.
  • A 4-year average of -$38.5 million and a median of -$36.0 million in 2019 frame the typical range for Income from Non-Controlling Interests.
  • Annual changes were most pronounced in 2020 — Income from Non-Controlling Interests tumbled 2000.0% — and 2021, when it jumped 126.32%.
  • Year by year, Income from Non-Controlling Interests stood at -$102.0 million in 2018, then surged by 103.92% to $4.0 million in 2019, then slumped by 2000.0% to -$76.0 million in 2020, then soared by 126.32% to $20.0 million in 2021.
  • According to Business Quant data, Income from Non-Controlling Interests over the past three periods registered $20.0 million, -$76.0 million, and $4.0 million for Q4 2021, Q4 2020, and Q4 2019 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 16.00 Mn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -2.00 Mn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn 22.00 Mn
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn -5.85 Mn
10 Steris 21.47 Bn 21.03 Bn 697.10 Mn 100,000.00

Historic Data

Download Data
DateValue
Dec 31, 2021 20.00 Mn
Dec 31, 2020 -76.00 Mn
Dec 31, 2019 4.00 Mn
Dec 31, 2018 -102.00 Mn
Dec 31, 2010 72.00 Mn
Sep 30, 2010 77.00
Jun 30, 2010 -183.00
Mar 31, 2010 77.00
Dec 31, 2009 91.00 Mn
Sep 30, 2009 42.00
Jun 30, 2009 -18.00
Mar 31, 2009 42.00